Centre creating 30-day stock of key Covid drugs
FOR 3RD WAVE
■ Centre asks states to procure essential medicines
■ Centre is buying 5 mn remdesivir vials and paying in advance
■ State govts stocking up common medicines/ supplements like paracetamol, antibiotics, vitamins
■ Firms told ensure no shortage of imported medicines
Ahead of the anticipated third wave, India is trying to build a buffer stock or inventory of essential Covid-19 medicines like remdesivir and favipiravir, besides common drugs and supplements like paracetamol, antibiotics, and vitamins. According to industry sources, the plan is to have a 30-day stock for key drugs like remdesivir, a shortage of which was witnessed during the first two waves.
“The Centre is planning to procure 5 million vials of remdesivir ahead of the third wave. What’s better is that this time, the government is paying us in advance,” said a senior executive of a Mumbaibased pharma player which makes remdesivir.
“During the second wave when we were told to scale up our capacities by two-threefolds, we had asked what would happen to the excess capacities in the future unless there was an assurance of offtake. This time, the government has not only placed orders for large volumes but is also paying us in advance.” The senior executive said India now has the capacity to make around 10 million remdesivir vials a month.
The drug had seen prices jump manifold in the black market, and patients were scrambling to procure their stock of medicines during the second wave. A patient typically needs six vials.
Sharvil Patel, MD of Cadila Healthcare, said the firm has a 3-month inventory of the drug, and confirmed that the Centre was looking at buying and stocking this injectable medicine. “India is trying to create an inventory that would last around 30 days. If a wave hits, manufacturers can produce fresh batches within that time,” Patel said. According to a government official: “Usually, a batch of remdesivir takes 15 days to make. This includes sterility testing requirements. If a manufacturer is using a certain type of sterile equipment in manufacturing, this testing requirement can be bypassed for now. This can halve the time required to make one batch.” State governments like Rajasthan and Gujarat, too, are trying to pile up the stock of other essential medicines.